{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:43:58Z","timestamp":1794998638147,"version":"4.9.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>We hypothesized that the origins of abruption may extend to the stages of placental implantation; however, there are no reliable markers to predict its development. Based on this hypothesis, we sought to evaluate whether first-trimester and second-trimester serum analytes predict placental abruption.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We performed a secondary analysis of data of 35,307 women (250 abruption cases) enrolled in the First and Second Trimester Evaluation of Risk cohort (1999\u20132003), a multicenter, prospective cohort study. Percentiles (based on multiples of the median) of first-trimester (pregnancy-associated plasma protein A and total and free \u03b2-hCG) and second-trimester (maternal serum alpha-fetoprotein, unconjugated estriol, and inhibin-A) serum analytes were examined in relation to abruption. Associations are based on risk ratio (RR) and 95% confidence interval (CI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Women with an abnormally low pregnancy-associated plasma protein A (fifth percentile or less) were at increased risk of abruption compared with those without abruption (9.6% compared with 5.3%; RR 1.9, 95% CI, 1.2\u20132.8). Maternal serum alpha-fetoprotein 95th percentile or greater was more common among abruption (9.6%) than nonabruption (5.1%) pregnancies (RR 1.9, 95% CI 1.3\u20133.0). Inhibin-A fifth percentile or less (8.0% compared with 5.1%; RR 1.8, 95% CI 1.1\u20132.9), and 95th percentile or greater (9.6% compared with 5.0%; RR 2.0, 95% CI 1.3\u20133.1) were associated with abruption. Women with all three abnormal pregnancy-associated plasma protein A, maternal serum alpha-fetoprotein, and inhibin-A analytes were at 8.8-fold (95% CI 2.3\u201334.3) risk of abruption. No associations were seen with other analytes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>These data provide support for our hypothesis that the origins of placental abruption may extend to the early stages of pregnancy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000001889","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T11:47:16Z","timestamp":1487850436000},"page":"465-472","source":"Crossref","is-referenced-by-count":35,"title":["First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption"],"prefix":"10.1097","volume":"129","author":[{"given":"Cande V.","family":"Ananth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Wapner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinidhi","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"D'Alton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Vintzileos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"e0125246","DOI":"10.1371\/journal.pone.0125246","article-title":"An international contrast of rates of placental abruption: an age-period-cohort analysis","volume":"10","author":"Ananth","year":"2015","journal-title":"PLoS One"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-3016.2001.00352.x","article-title":"Placental abruption and perinatal death","volume":"15","author":"Kyrklund-Blomberg","year":"2001","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/14767058.2010.511346","article-title":"Placental abruption: critical analysis of risk factors and perinatal outcomes","volume":"24","author":"Pariente","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"272.e1","DOI":"10.1016\/j.ajog.2015.09.069","article-title":"Severe placental abruption: clinical definition and associations with maternal complications","volume":"214","author":"Ananth","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10654-015-0067-9","article-title":"Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden","volume":"31","author":"DeRoo","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ppe.12089","article-title":"Placental abruption as a significant risk factor for long-term cardiovascular mortality in a follow-up period of more than a decade","volume":"28","author":"Pariente","year":"2014","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/aje\/153.4.332","article-title":"Placental abruption and perinatal mortality in the United States","volume":"153","author":"Ananth","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejogrb.2006.01.016","article-title":"Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions","volume":"128","author":"Ananth","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9378(97)70455-1","article-title":"The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction","volume":"177","author":"Cnattingius","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1001\/jama.282.17.1646","article-title":"Placental abruption and adverse perinatal outcomes","volume":"282","author":"Ananth","year":"1999","journal-title":"JAMA"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ajog.2006.05.021","article-title":"Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth","volume":"195","author":"Ananth","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3109\/14767050903334885","article-title":"Ischemic placental disease: maternal versus fetal clinical presentations by gestational age","volume":"23","author":"Ananth","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down's syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1148\/radiology.182.2.1732970","article-title":"Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US","volume":"182","author":"Hadlock","year":"1992","journal-title":"Radiology"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pd.1326","article-title":"Stability of first- and second-trimester serum markers after storage and shipment","volume":"26","author":"Lambert-Messerlian","year":"2006","journal-title":"Prenat Diagn"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/01.AOG.0000241095.19638.f2","article-title":"Comparison of serum markers in first-trimester down syndrome screening","volume":"108","author":"Canick","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","article-title":"First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)","volume":"191","author":"Dugoff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.ajog.2014.03.027","article-title":"Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption","volume":"211","author":"Blumenfeld","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejogrb.2011.03.004","article-title":"Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption","volume":"157","author":"Ranta","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/uog.3881","article-title":"Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation","volume":"29","author":"Pilalis","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/pd.407","article-title":"Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome","volume":"22","author":"Yaron","year":"2002","journal-title":"Prenat Diagn"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ajog.2004.05.068","article-title":"Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes","volume":"191","author":"Krantz","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/uog.15849","article-title":"Maternal serum PAPP-A and free beta-hCG at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia","volume":"47","author":"Wright","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.292.18.2249","article-title":"First-trimester placentation and the risk of antepartum stillbirth","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0002-9378(97)70019-X","article-title":"Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia","volume":"177","author":"Spong","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1067\/S0002-9378(03)00769-5","article-title":"Unexplained elevated maternal serum alpha-fetoprotein and\/or human chorionic gonadotropin and the risk of adverse outcomes","volume":"189","author":"Chandra","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0002-9378(12)80033-0","article-title":"Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes","volume":"167","author":"Williams","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/pd.1654","article-title":"Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption","volume":"27","author":"Tikkanen","year":"2007","journal-title":"Prenat Diagn"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2265.1995.tb02648.x","article-title":"Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy","volume":"42","author":"Muttukrishna","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000322742","article-title":"Early detection of preeclampsia using inhibin a and other second-trimester serum markers","volume":"29","author":"Ree","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","article-title":"Obstetrical complications associated with abnormal maternal serum markers analytes","volume":"30","author":"Gagnon","year":"2008","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201703000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T18:05:37Z","timestamp":1689098737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201703000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001889","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}